{
    "ticker": "PRTC",
    "name": "Portage Biotech Inc.",
    "description": "Portage Biotech Inc. is a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies for cancer and other serious diseases. Founded in 2014, Portage is focused on advancing its proprietary technologies and platforms, which include immune-oncology and targeted therapies. The company aims to improve the lives of patients by developing novel treatments that harness the body's immune system to combat cancer. Portage's pipeline includes several promising candidates that are currently in various stages of clinical trials, addressing unmet medical needs in oncology. The company collaborates with leading research institutions and biopharmaceutical companies to expedite the development of its therapies. With a commitment to scientific excellence and patient-centric innovation, Portage Biotech is poised to make significant contributions to the field of oncology and beyond.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Toronto, Ontario, Canada",
    "founded": "2014",
    "website": "https://www.portagebiotech.com",
    "ceo": "Dr. Ian Walters",
    "social_media": {
        "twitter": "https://twitter.com/PortageBiotech",
        "linkedin": "https://www.linkedin.com/company/portage-biotech/"
    },
    "investor_relations": "https://www.portagebiotech.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Ian Walters",
            "position": "CEO"
        },
        {
            "name": "Dr. John D. M. Laird",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology Therapies",
            "products": [
                "PTG-300",
                "PTG-200"
            ]
        }
    ],
    "seo": {
        "meta_title": "Portage Biotech Inc. | Innovative Cancer Therapies",
        "meta_description": "Explore Portage Biotech Inc., a leader in developing advanced therapies for cancer. Learn about their pipeline, mission, and impact on oncology.",
        "keywords": [
            "Portage Biotech",
            "Cancer Treatment",
            "Biopharmaceuticals",
            "Immunotherapy",
            "Oncology",
            "Clinical Trials"
        ]
    },
    "faq": [
        {
            "question": "What does Portage Biotech focus on?",
            "answer": "Portage Biotech focuses on developing innovative therapies for cancer and other serious diseases."
        },
        {
            "question": "Who is the CEO of Portage Biotech?",
            "answer": "Dr. Ian Walters is the CEO of Portage Biotech Inc."
        },
        {
            "question": "Where is Portage Biotech headquartered?",
            "answer": "Portage Biotech is headquartered in Toronto, Ontario, Canada."
        },
        {
            "question": "What are some of Portage's key products?",
            "answer": "Some of Portage's key products include PTG-300 and PTG-200, which are in various stages of clinical development."
        },
        {
            "question": "When was Portage Biotech founded?",
            "answer": "Portage Biotech was founded in 2014."
        }
    ],
    "competitors": [
        "JAZZ",
        "EXEL",
        "CLVS",
        "NK"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "MRNA"
    ]
}